OOIR: Observatory of International Research

Papers

(The TQCC of Rheumatic Disease Clinics of North America is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)

Article	Citations
Racial/Ethnic, Socioeconomic, and Geographic Disparities in the Epidemiology of Knee and Hip Osteoarthritis	40
Risk Factors and Cancer Screening in Myositis	26
Rheumatoid Arthritis	25
Racial/Ethnic and Socioeconomic Disparities in Osteoarthritis Management	24
Pathogenesis and Treatment of Refractory Disease Courses in Systemic Juvenile Idiopathic Arthritis	24
Osteoarthritis Treatment Guidelines from Six Professional Societies	24
Gender and Ethnic Inequities in Gout Burden and Management	23
Axial Psoriatic Arthritis	22
Basic Mechanisms of Pain in Osteoarthritis	22
Cancer and Systemic Lupus Erythematosus	21
Understanding Lupus Disparities Through a Social Determinants of Health Framework	21
Cancer and Rheumatoid Arthritis	18
Treatment Guidelines in Rheumatoid Arthritis	18
Systemic Lupus Erythematosus Classification and Diagnosis	14
Socioeconomic Status, Health Care, and Outcomes in Systemic Lupus Erythematosus	14
COVID-19 in Pediatrics	14
Disparities in Lupus and Lupus Nephritis Care and Outcomes Among US Medicaid Beneficiaries	14
Cancer and Scleroderma	14
Classification Criteria in Axial Spondyloarthritis	13
Health Disparities in Systemic Lupus Erythematosus	13
(Health-Related) Quality of Life as an Outcome in Studies of Axial Spondyloarthritis	13
Use of Quality Measures to Identify Disparities in Health Care for Systemic Lupus Erythematosus	12
Recent Updates in Juvenile Spondyloarthritis	12
Neutrophil Dysregulation in the Pathogenesis of Systemic Lupus Erythematosus	12
Autoimmunity, Clonal Hematopoiesis, and Myeloid Neoplasms	12

B Cells in Systemic Lupus Erythematosus	12
Targeting Nerve Growth Factor for Pain Management in Osteoarthritis—Clinical Efficacy and Safety	12
Risk of Malignancy in Spondyloarthritis	12
Racial Disparities in Rheumatology Through the Lens of Critical Race Theory	11
Racial Disparities in Systemic Sclerosis	11
Abnormal Mitochondrial Physiology in the Pathogenesis of Systemic Lupus Erythematosus	10
Sjögren Syndrome and Cancer	10
Treat to Target in Axial Spondyloarthritis	10
Juvenile-Versus Adult-Onset Spondyloarthritis	10
Low Back Pain in Adolescent and Geriatric Populations	9
Interferons in Systemic Lupus Erythematosus	9
Juvenile Localized Scleroderma	9
The Power of Systems Biology	9
Intestinal Microbiota, HLA-B27, and Spondyloarthritis	8
Updates on Juvenile Dermatomyositis from the Last Decade: Classification to Outcomes	8
Pathogenesis of Axial Spondyloarthritis — Sources and Current State of Knowledge	8
Disparities in Rheumatoid Arthritis Care and Health Service Solutions to Equity	8
Paraneoplastic Musculoskeletal Syndromes	7
Pain Mechanisms in Patients with Rheumatic Diseases	7
Mental Health in Pediatric Rheumatology	7
The Temporomandibular Joint in Juvenile Idiopathic Arthritis	7
Health Disparities in Rheumatic Diseases	7
T Cells in Systemic Lupus Erythematosus	7
Disparities in Childhood-Onset Lupus	7
Systemic Autoinflammatory Diseases	6
What Does Human Leukocyte Antigen B27 Have to Do with Spondyloarthritis?	6
Uveitis in Children and Adolescents	6
Environmental Triggers of Hyperuricemia and Gout	6
Recommendations for Systemic Lupus Erythematosus	6
Chronic Nonbacterial Osteomyelitis	6
Treatment Update in Systemic Lupus Erythematous	6
Emerging Imaging Techniques in Spondyloarthritis	6
Designing an Intervention to Improve Management of High-Risk Lupus Patients Through Care Coordination	6
Leveraging Telemedicine as an Approach to Address Rheumatic Disease Health Disparities	6
Understanding the Disproportionate Burden of Rheumatic Diseases in Indigenous North American Populations	6
The Categorization of Pain in Systemic Lupus Erythematosus	6
Juvenile Idiopathic Arthritis Treatment Updates	6
Management of Pregnancy in Lupus	6
Juvenile Fibromyalgia	5
Unique Aspects of Pediatric Sjögren Disease	5
Ultrasonography in Pediatric Rheumatology	5
Pharmacosurveillance in Juvenile Idiopathic Arthritis	5
Behçet Syndrome	5
Why It Hurts	5
Pain in Axial Spondyloarthritis	5
Disparities in Pediatric Rheumatic Diseases	5
Updates in Systemic Sclerosis Treatment and Applicability to Pediatric Scleroderma	5
Fibromyalgia	5
Understanding Risk Factors for Poor Outcomes in a Multiethnic Longitudinal Cohort	5
The Contribution of Genetics and Epigenetics to Our Understanding of Health Disparities in Rheumatic Diseases	5

Systemic Lupus Erythematosus Outcome Measures for Systemic Lupus Erythematosus Clinical Trials	4
Treatment Guidelines in Vasculitis	4
Cardiovascular Health in Pediatric Rheumatologic Diseases	4
Kawasaki Disease and Multisystem Inflammatory Syndrome in Children	4
Lifestyle, Hormonal, and Metabolic Environmental Risks for Rheumatoid Arthritis	4
Axial Spondyloarthritis in the Era of Precision Medicine	4
Suspecting and Diagnosing the Patient with Spondyloarthritis and What to Expect from Therapy	4
Therapeutic Advances in Eosinophilic Granulomatosis with Polyangiitis	4
Implementation Science in Pediatric Rheumatology: A Path to Health Equity	4
Sexual Dimorphism in the Expression of Pain Phenotype in Preclinical Models of Rheumatoid Arthritis	4
Instrumental Substance Use Among Youth with Rheumatic Disease—A Biopsychosocial Model	4
The Meaningful Role of Patients, and Other Stakeholders in Clinical Practice Guideline Development	4
The Patient’s Perspective on the Burden of Disease in Ankylosing Spondylitis	4